Home › NDC Lookup › Ingredients › Amphetamine Extended-Release
📦 NDC / package directory — not a drug information page

Amphetamine Extended-Release NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Amphetamine Extended-Release products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

6
Package NDCs
12
Products
12
Active listings
0
Discontinued
1
Labelers
6
Strengths
1
Dosage forms
6
With NADAC pricing

By strength, form & labeler

NDC products by strength
AMPHETAMINE 6.3 mg/1 2
AMPHETAMINE 18.8 mg/1 2
AMPHETAMINE 3.1 mg/1 2
AMPHETAMINE 15.7 mg/1 2
AMPHETAMINE 9.4 mg/1 2
AMPHETAMINE 12.5 mg/1 2
By dosage form
TABLET, ORALLY DISINTEGRATING 12
Top labelers
Neos Therapeutics, LP 12

Browse records — 12 products

Drug / product Billing NDC NADAC / unit Status
Amphetamine Extended-Release 6.3 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0010-30 · 30 BLISTER PACK in 1 CARTON (62542-010-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0010-30 $16.073 /unit · NADAC On market View →
Amphetamine Extended-Release 18.8 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0030-30 · 30 BLISTER PACK in 1 CARTON (62542-030-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0030-30 $15.614 /unit · NADAC On market View →
Amphetamine Extended-Release 3.1 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0005-30 · 30 BLISTER PACK in 1 CARTON (62542-005-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0005-30 $15.842 /unit · NADAC On market View →
Amphetamine Extended-Release 15.7 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0025-30 · 30 BLISTER PACK in 1 CARTON (62542-025-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0025-30 $15.929 /unit · NADAC On market View →
Amphetamine Extended-Release 9.4 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0015-30 · 30 BLISTER PACK in 1 CARTON (62542-015-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0015-30 $16.218 /unit · NADAC On market View →
Amphetamine Extended-Release 12.5 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0020-30 · 30 BLISTER PACK in 1 CARTON (62542-020-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0020-30 $15.962 /unit · NADAC On market View →
Amphetamine Extended-Release 18.8 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0030-30 · 30 BLISTER PACK in 1 CARTON (62542-030-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0030-30 $15.614 /unit · NADAC On market View →
Amphetamine Extended-Release 6.3 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0010-30 · 30 BLISTER PACK in 1 CARTON (62542-010-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0010-30 $16.073 /unit · NADAC On market View →
Amphetamine Extended-Release 15.7 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0025-30 · 30 BLISTER PACK in 1 CARTON (62542-025-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0025-30 $15.929 /unit · NADAC On market View →
Amphetamine Extended-Release 9.4 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0015-30 · 30 BLISTER PACK in 1 CARTON (62542-015-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0015-30 $16.218 /unit · NADAC On market View →
Amphetamine Extended-Release 3.1 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0005-30 · 30 BLISTER PACK in 1 CARTON (62542-005-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0005-30 $15.842 /unit · NADAC On market View →
Amphetamine Extended-Release 12.5 mg/1 TABLET, ORALLY DISINTEGRATING Neos · NDC 62542-0020-30 · 30 BLISTER PACK in 1 CARTON (62542-020-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 62542-0020-30 $15.962 /unit · NADAC On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.